Mankind Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,162.60
98.8 (4.79%)
BSENSE

Feb 03

BSE+NSE Vol: 7.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lupin
Glenmark Pharma
Torrent Pharma
Aurobindo Pharma
Alkem Lab
Biocon
Abbott India
Dr Reddy's Labs
Zydus Lifesci.
Cipla
Mankind Pharma

Why is Mankind Pharma Ltd ?

1
Flat results in Dec 25
  • ROCE(HY) Lowest at 12.33%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 7.13 times
2
With ROCE of 11.7, it has a Expensive valuation with a 4.6 Enterprise value to Capital Employed
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -16.50%, its profits have fallen by -17.2%
3
Below par performance in long term as well as near term
  • Along with generating -16.50% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Mankind Pharma for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Mankind Pharma
-16.24%
-0.64
25.54%
Sensex
8.49%
0.74
11.41%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
19.85%
EBIT Growth (5y)
14.48%
EBIT to Interest (avg)
40.81
Debt to EBITDA (avg)
1.27
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.81
Tax Ratio
18.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.59%
ROCE (avg)
21.63%
ROE (avg)
16.64%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
51
Industry P/E
32
Price to Book Value
5.82
EV to EBIT
39.13
EV to EBITDA
28.85
EV to Capital Employed
4.59
EV to Sales
6.96
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
11.72%
ROE (Latest)
11.44%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 5.85 times

PBT LESS OI(Q)

Highest at Rs 542.84 cr.

-3What is not working for the Company
ROCE(HY)

Lowest at 12.33%

DEBTORS TURNOVER RATIO(HY)

Lowest at 7.13 times

Loading Valuation Snapshot...

Here's what is working for Mankind Pharma

Operating Profit to Interest - Quarterly
Highest at 5.85 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 542.84 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 542.84 cr has Grown at 30.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 416.47 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Mankind Pharma

Debtors Turnover Ratio- Half Yearly
Lowest at 7.13 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio